SANGAMO THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 2567000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2016-03-31) |
| Status | current |
| Entity | SANGAMO THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:46.934068+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b831ff52-aa92-4692-ad38-447f727b6224
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-16-018000Retrieved: 2026-08-19T09:41:46.934068+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001233/accounts-receivable/2016-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b831ff52-aa92-4692-ad38-447f727b6224
History
- no predecessors — first report